2,806
Views
33
CrossRef citations to date
0
Altmetric
Reviews

Current status and future prospects of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) clinical trials in ovarian cancer

, , &
Pages 548-553 | Received 16 Nov 2016, Accepted 12 Jan 2017, Published online: 30 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Eelco de Bree & Dimosthenis Michelakis. (2020) An overview and update of hyperthermic intraperitoneal chemotherapy in ovarian cancer. Expert Opinion on Pharmacotherapy 21:12, pages 1479-1492.
Read now
H. Petra Kok, Erik N. K. Cressman, Wim Ceelen, Christopher L. Brace, Robert Ivkov, Holger Grüll, Gail ter Haar, Peter Wust & Johannes Crezee. (2020) Heating technology for malignant tumors: a review. International Journal of Hyperthermia 37:1, pages 711-741.
Read now
Zhongyuan Tang, Weiwei Feng, Yiqing Yang & Qun Wang. (2019) Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies. Drug Design, Development and Therapy 13, pages 3281-3290.
Read now
Qiwen Wu, Qianqian Wu, Jianying Xu, Xiaodong Cheng, Xinyu Wang, Weiguo Lu & Xiao Li. (2019) Efficacy of hyperthermic intraperitoneal chemotherapy in patients with epithelial ovarian cancer: a meta-analysis. International Journal of Hyperthermia 36:1, pages 561-571.
Read now
Vladimir G. Bespalov, Ivan K. Alvovsky, Grigory V. Tochilnikov, Alexandr N. Stukov, Ekaterina A. Vyshinskaya, Alexandr L. Semenov, Irina N. Vasilyeva, Olesya A. Belyaeva, Galina S. Kireeva, Konstantin Y. Senchik, Nadezhda T. Zhilinskaya, Julia D. Von, Larisa A. Krasilnikova, Valery A. Alexandrov, Nikita N. Khromov-Borisov, Denis A. Baranenko & Alexey M. Belyaev. (2018) Comparative efficacy evaluation of catheter intraperitoneal chemotherapy, normothermic and hyperthermic chemoperfusion in a rat model of ascitic ovarian cancer. International Journal of Hyperthermia 34:5, pages 545-550.
Read now

Articles from other publishers (27)

Julia H. Gelissen, Naomi N. Adjei, Blair McNamara, Levent Mutlu, Justin A. Harold, Mitchell Clark, Gary Altwerger, Peter R. Dottino, Gloria S. Huang, Alessandro D. Santin, Masoud Azodi, Elena Ratner, Peter E. Schwartz & Vaagn Andikyan. (2023) Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. Annals of Surgical Oncology 30:9, pages 5597-5609.
Crossref
Silvia Breusa, Serena Zilio, Giuseppina Catania, Naoual Bakrin, David Kryza & Giovanna Lollo. (2023) Localized chemotherapy approaches and advanced drug delivery strategies: a step forward in the treatment of peritoneal carcinomatosis from ovarian cancer. Frontiers in Oncology 13.
Crossref
Aaron M. Praiss, Qin Zhou, Alexia Iasonos, Lea Moukarzel, Kimberly Dessources, Krysten Soldan, Katy Su, Yukio Sonoda, Kara Long Roche, Ginger J. Gardner, Tiffany Troso-Sandoval, William P. Tew, Rachel N. Grisham, Dennis S. Chi, Roisin E. O'Cearbhaill & Oliver Zivanovic. (2023) Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial. Gynecologic Oncology 171, pages 23-30.
Crossref
Aaron M. Praiss, Lea A. Moukarzel & Oliver Zivanovic. (2023) Is there a role for hyperthermic intraperitoneal chemotherapy in ovarian cancer?. Current Opinion in Obstetrics & Gynecology 35:1, pages 21-26.
Crossref
Sarah H. Kim, Roisin E. O’Cearbhaill, Preetha Ramalingam & Jennifer J. Mueller. 2023. Diagnosis and Treatment of Rare Gynecologic Cancers. Diagnosis and Treatment of Rare Gynecologic Cancers 77 93 .
Myong Cheol Lim, Suk-Joon Chang, Boram Park, Heon Jong Yoo, Chong Woo Yoo, Byung Ho Nam, Sang-Yoon Park, Sang-Soo Seo, Sokbom Kang, Jung Yeon Yun, Dae-Soon Cho, Sun Ho Kim, Tae-Sung Kim, Sung Sil Park, Dong Woon Lee, Sung Chan Park, Hyeong Min Park, Sung-Sik Han, Seoung Hoon Kim, Hee Chul Yang, Moon Soo Kim, Jong Mog Lee, Bang Wool Eom, Young Il Kim, Hong Man Yoon, Il Ju Choi, Sung Han Kim, Jae Young Joung, Ho Kyung Seo, Jung Nam Joo, Yong Jung Song, Sae Hyun Park, Dae Chul Jung, Min Jung Kim, Ji Won Park, Seung-Yong Jeong, Young Ho Yun, Sohee Park & Robert E Bristow. (2022) Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer. JAMA Surgery 157:5, pages 374.
Crossref
TETSUO ADACHI. (2022) Antitumor Activity of Non-thermal Atmospheric Pressure Plasma and Synergistic Effects of Hyperthermia大気圧低温プラズマの抗がん作用とhyperthermiaの併用効果. Thermal Medicine 38:1, pages 1-18.
Crossref
Xiaoli He, Li Wei, Rui Li, Shuang Jing, Linlin Jia, Danwei Ji, Yali Li, Yue Wang & Yongxia Zhu. (2021) Dense hyperthermic intraperitoneal chemotherapy with cisplatin in patients with stage III serous epithelial ovarian cancer: a retrospective study. BMC Cancer 21:1.
Crossref
Tetsuo Adachi. (2021) Molecular Mechanisms Underlying Cellular Responses to the Loading of Non-thermal Atmospheric Pressure Plasma-activated Solutions大気圧低温プラズマ照射溶液の負荷に対する細胞応答の分子機構. YAKUGAKU ZASSHI 141:10, pages 1185-1194.
Crossref
Jieun Ko, Hyeong In Ha, Min Chul Choi, Sang Geun Jung, Hyun Park, Won Duk Joo, Seung Hun Song, Chan Lee & Joon Mo Lee. (2021) Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer. Obstetrics & Gynecology Science 64:5, pages 437-443.
Crossref
Jue Zhang, Xin-bao Li, Zhong-he Ji, Ru Ma, Wen-pei Bai & Yan Li. (2021) Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients. BioMed Research International 2021, pages 1-12.
Crossref
John H. StewartIVIV, Dan G. BlazerIIIIII, Maria Jose Godoy Calderon, Taylor M. Carter, Austin Eckhoff, Mohammad A. Al Efishat, Deemantha G. Fernando, Jason M. Foster, Andrea Hayes-Jordan, Fabian M. Johnston, Timothy B. Lautz, Edward A. Levine, Ugwuji N. Maduekwe, Christopher W. Mangieri, Omeed Moaven, Harveshp Mogal, Perry Shen & Konstantinos I. Votanopoulos. (2021) The Evolving Management of Peritoneal Surface Malignancies. Current Problems in Surgery 58:4, pages 100860.
Crossref
Michael Friedrich, Dominique Friedrich, Clayton Kraft, Walther Kuhn & Christoph Rogmans. 2021. Ovarian Cancer - Updates in Tumour Biology and Therapeutics [Working Title]. Ovarian Cancer - Updates in Tumour Biology and Therapeutics [Working Title].
S.E. Voskanyan, A.E. Kucheryavyi, T.V. Sutorma & A.I. Artemyev. (2021) The role of hyperthermic intraperitoneal intraoperative chemoperfusion in the treatment of ovarian cancer. Onkologiya. Zhurnal imeni P.A.Gertsena 10:3, pages 54.
Crossref
Rika Ishii, Tetsuro Kamiya, Hirokazu Hara & Tetsuo Adachi. (2020) Hyperthermia synergistically enhances cancer cell death by plasma-activated acetated Ringer's solution. Archives of Biochemistry and Biophysics 693, pages 108565.
Crossref
Aurélie Revaux, Marie Carbonnel, Frédéric Kanso, Iptissem Naoura, Jennifer Asmar, Philippe Kadhel & Jean-Marc Ayoubi. (2020) Hyperthermic intraperitoneal chemotherapy in ovarian cancer: an update. Hormone Molecular Biology and Clinical Investigation 41:3.
Crossref
Feifan Xie, Jan Van Bocxlaer, Pieter Colin, Charlotte Carlier, Olivier Van Kerschaver, Joseph Weerts, Hannelore Denys, Philippe Tummers, Wouter Willaert, Wim Ceelen & An Vermeulen. (2020) PKPD Modeling and Dosing Considerations in Advanced Ovarian Cancer Patients Treated with Cisplatin-Based Intraoperative Intraperitoneal Chemotherapy. The AAPS Journal 22:5.
Crossref
Ziying Lei, Yue Wang, Jiahong Wang, Ke Wang, Jun Tian, Ying Zhao, Lipai Chen, Jin Wang, Jiali Luo, Manman Jia, Hongsheng Tang, Qingjun He, Quanxing Liao, Xiansheng Yang, Tianpei Guan, Li Wang & Shuzhong Cui. (2020) Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer. JAMA Network Open 3:8, pages e2013940.
Crossref
Michele De Simone, Marco Vaira, Monica Argenziano, Paola Berchialla, Alberto Pisacane, Armando Cinquegrana, Roberta Cavalli, Alice Borsano & Manuela Robella. (2020) Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial. Biomedicines 8:5, pages 102.
Crossref
Christos Iavazzo, Alexandros Fotiou, M. Tsiatas, Athina Christopoulou, John Spiliotis & Paul Sugarbaker. (2020) Survey on the current gynaecological approach of ovarian cancer patients: The utility of HIPEC. Pleura and Peritoneum 5:1.
Crossref
McKayla J. Riggs, Prakash K. Pandalai, Joseph Kim & Charles S. Dietrich. (2020) Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. Diagnostics 10:1, pages 43.
Crossref
Heon Jong Yoo, Myong Cheol Lim, Sang-Soo Seo, Sokbom Kang, Jungnam Joo & Sang-Yoon Park. (2019) Phase I/II clinical trial of modulated electro-hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer. Japanese Journal of Clinical Oncology 49:9, pages 832-838.
Crossref
Mette Schou Mikkelsen, Thora Christiansen, Lone Kjeld Petersen, Jan Blaakaer & Lene Hjerrild Iversen. (2019) Morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with carboplatin used for ovarian, tubal, and primary peritoneal cancer. Journal of Surgical Oncology 120:3, pages 550-557.
Crossref
Stephanie L. Lim, Laura J. Havrilesky, Ashraf S. Habib & Angeles Alvarez Secord. (2019) Cost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy. Gynecologic Oncology 153:2, pages 376-380.
Crossref
Samira Zirak-Schmidt & Victor J. Verwaal. (2018) Hyperthermic Intraperitoneal Chemotherapy (HIPEC) as Primary Treatment of Ovarian Cancer: A Review of the Current Literature. Indian Journal of Gynecologic Oncology 16:3.
Crossref
Aditi Bhatt & Kiran K. Turaga. 2018. Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond. Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond 507 526 .
Aditi Bhatt, Naoual Bakrin & Olivier Glehen. 2018. Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond. Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond 253 280 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.